Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patients

American Journal Geriatric Pharmacotherapy

Volumn 10, Issue 2, 2012, Pages

  Solem, Caitlyn T ^a   Lee, Todd A ^a,b   Joo, Min J ^a   Lambert, Bruce L ^a   Walton, Surrey M ^a   Pickard, A Simon ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

COPD; medication exposure; pharmacoepidemiology; pharmacotherapy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84862802007     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.12.003     Document Type: Article

References (19)

1. Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci. 2008;30:509-514.
2. Restrepo RD, Alvarez MT, Wittnebel ND, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371-384.
3. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008;63:831-838.
4. Rand CS, Nides M, Cowles MK, et al. Long-term metered- dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1995;152:580-588.
5. Cramer JA, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J. 2007;14:25-29. (Pubitemid 46637657)
6. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2008), I. Medical Communications Resources, Editor. 2008, Global Initiative for Chronic Obstructive Lung Disease. http:// www.goldcopd.org/guidelines-global-strategy-for-diagnosis- management.html. Accessed May 14, 2010.
7. Joo MJ, Lee TA, Au DH, et al. Medication use patterns associated with spirometry in diagnosing COPD. COPD. 2008;5:360-368.
8. Mehuys E, Boussery K, Adriaens E, et al. COPD management in primary care: an observational, community pharmacy- based study. Ann Pharmacother. 2010;44:257-266.
9. Lee TA, Pickard AS, Au DH, et al. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med. 2008;149:380-390.
10. Fincke BG, Snyder K, Cantillon C, et al. Three complementary definitions of multiple respiratory medication use: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf. 2005;14:121-128. (Pubitemid 40253621)
11. Hayes BD, Klein-Schwartz W, Barrueto F Jr. Multiple respiratory medication use and the geriatric patient. Clin Geriatr Med. 2007;23:371-390, vii.
12. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-1465. (Pubitemid 29493800)
13. Foster JA, Yawn BP, Maziar A, et al. Enhancing COPD management in primary care settings. MedGenMed. 2007;9:24.
14. VA/DoD Clinical Practice Guideline for Management of Outpatient Chronic Obstructive Pulmonary Disease. 2007 [cited 2010 May 14]; Version 2.0. http://www. healthquality.va.gov/chronic-obstructive-pulmonary-disease-copd.asp. Accessed May 14, 2010.
15. Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: theCAGEstudy. Can Respir J. 2008;15:13-19. (Pubitemid 351575058)
16. Weidinger P, Nilsson JL, Lindblad U. Adherence to diagnostic guidelines and quality indicators in asthma and COPD in Swedish primary care. Pharmacoepidemiol Drug Saf. 2009;18:393-400.
17. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006;129:1509-1515. (Pubitemid 43894979)
18. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44-47. (Pubitemid 351160875)
19. Petri H, Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med. 1991;10:577-581.